Rapport Therapeutics, Inc. (RAPP) EBITDA

Annual EBITDA:

-$82.22M-$46.15M(-127.95%)
December 31, 2024

Summary

  • As of today, RAPP annual EBITDA is -$82.22 million, with the most recent change of -$46.15 million (-127.95%) on December 31, 2024.
  • During the last 3 years, RAPP annual EBITDA has fallen by -$71.86 million (-694.20%).
  • RAPP annual EBITDA is now -694.20% below its all-time high of -$10.35 million, reached on December 31, 2022.

Performance

1-Year Change

-127.95%

3-Year Change

-694.2%

5-Year Change

-694.2%

15-Year Change

-694.2%

RAPP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

20.62%
RAPP annual EBITDA is higher than 20.62% of companies in Healthcare sector

Range

All-Time High

-$10.35M
RAPP annual EBITDA is currently -694.20% below its historical high of -$10.35 million

3-Year Low

-$82.22M
RAPP annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RAPP previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 10, 2026
RAPP next annual earnings announcement is scheduled for Mar 10, 2026

OtherRAPPincome statement metrics

Annual Revenue

$0.00
RAPP annual revenue is $0.00

Annual Net Income

-$78.31M
RAPP annual net profit is -$78.31 million

Annual EBIT

-$83.06M
RAPP annual earnings before interest & taxes is -$83.06 million

Annual EPS

-$2.14
RAPP annual earnings per share is -$2.14

Quarterly EBITDA:

-$29.73M-$486.00K(-1.66%)
September 30, 2025

Summary

  • As of today, RAPP quarterly EBITDA is -$29.73 million, with the most recent change of -$486.00 thousand (-1.66%) on September 30, 2025.
  • Over the past year, RAPP quarterly EBITDA has dropped by -$8.31 million (-38.79%).
  • RAPP quarterly EBITDA is now -474.38% below its all-time high of -$5.18 million, reached on March 31, 2023.

Performance

3-Month Change

-1.66%

1-Year Change

-38.79%

3-Year Change

-474.38%

5-Year Change

-474.38%

RAPP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

14.99%
RAPP quarterly EBITDA is higher than 14.99% of companies in Healthcare sector

Range

All-Time High

-$5.18M
RAPP quarterly EBITDA is currently -474.38% below its historical high of -$5.18 million

3-Year Low

-$29.73M
RAPP quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
RAPP previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 10, 2026
RAPP next earnings announcement is scheduled for Mar 10, 2026

OtherRAPPincome statement metrics

Quarterly Revenue

$0.00
RAPP quarterly revenue is $0.00

Quarterly Net Income

-$26.93M
RAPP quarterly net profit is -$26.93 million

Quarterly EBIT

-$29.99M
RAPP quarterly earnings before interest & taxes is -$29.99 million

Quarterly EPS

-$0.71
RAPP quarterly earnings per share is -$0.71

TTM EBITDA:

-$109.10M-$8.31M(-8.24%)
September 30, 2025

Summary

  • As of today, RAPP TTM EBITDA is -$109.10 million, with the most recent change of -$8.31 million (-8.24%) on September 30, 2025.
  • Over the past year, RAPP TTM EBITDA has dropped by -$50.14 million (-85.05%).
  • RAPP TTM EBITDA is now -2007.79% below its all-time high of -$5.18 million, reached on March 31, 2023.

Performance

3-Month Change

-8.24%

1-Year Change

-85.05%

3-Year Change

-2007.79%

5-Year Change

-2007.79%

RAPP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

15.35%
RAPP TTM EBITDA is higher than 15.35% of companies in Healthcare sector

Range

All-Time High

-$5.18M
RAPP TTM EBITDA is currently -2007.79% below its historical high of -$5.18 million

3-Year Low

-$109.10M
RAPP TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
RAPP previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 10, 2026
RAPP next earnings announcement is scheduled for Mar 10, 2026

OtherRAPPincome statement metrics

TTM Revenue

$0.00
RAPP TTM revenue is $0.00

TTM Net Income

-$97.70M
RAPP TTM net profit is -$97.70 million

TTM EBIT

-$110.11M
RAPP TTM earnings before interest & taxes is -$110.11 million

TTM EPS

-$2.69
RAPP TTM earnings per share is -$2.69

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$82.22M
RAPP annual EBITDA is -$82.22 million

Annual Net Income

-$78.31M
RAPP annual net profit is -$78.31 million

Annual Interest Expense

$0.00
RAPP annual interest expense is $0.00

Annual Income Tax

$0.00
RAPP annual income tax is $0.00

Annual D&A

$839.00K
RAPP annual D&A is $839.00 thousand

RAPP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-128.0%-38.8%-85.0%
3Y3 Years-694.2%-474.4%-2007.8%
5Y5 Years-694.2%-474.4%-2007.8%

RAPP EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-694.2%at low-474.4%at low-2007.8%at low
5Y5-Year-694.2%at low-474.4%at low-2007.8%at low
All-TimeAll-Time-694.2%at low-474.4%at low-2007.8%at low

RAPP EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$29.73M(-1.7%)
-$109.10M(-8.2%)
Jun 2025
-
-$29.24M(-8.9%)
-$100.79M(-9.4%)
Mar 2025
-
-$26.86M(-15.5%)
-$92.14M(-12.1%)
Dec 2024
-$82.22M
-$23.26M(-8.6%)
-$82.22M(-39.5%)
Sep 2024
-
-$21.42M(-4.0%)
-$58.95M(-57.1%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$20.59M(-21.5%)
-$37.53M(-59.4%)
Mar 2024
-
-$16.94M(-156.3%)
-$23.55M(-99.8%)
Dec 2023
-$36.07M(-248.4%)
-
-
Jun 2023
-
-$6.61M(-27.7%)
-$11.79M(-127.7%)
Mar 2023
-
-$5.18M
-$5.18M
Dec 2022
-$10.35M
-
-

FAQ

  • What is Rapport Therapeutics, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Rapport Therapeutics, Inc.?
  • What is Rapport Therapeutics, Inc. annual EBITDA year-on-year change?
  • What is Rapport Therapeutics, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Rapport Therapeutics, Inc.?
  • What is Rapport Therapeutics, Inc. quarterly EBITDA year-on-year change?
  • What is Rapport Therapeutics, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Rapport Therapeutics, Inc.?
  • What is Rapport Therapeutics, Inc. TTM EBITDA year-on-year change?

What is Rapport Therapeutics, Inc. annual EBITDA?

The current annual EBITDA of RAPP is -$82.22M

What is the all-time high annual EBITDA for Rapport Therapeutics, Inc.?

Rapport Therapeutics, Inc. all-time high annual EBITDA is -$10.35M

What is Rapport Therapeutics, Inc. annual EBITDA year-on-year change?

Over the past year, RAPP annual EBITDA has changed by -$46.15M (-127.95%)

What is Rapport Therapeutics, Inc. quarterly EBITDA?

The current quarterly EBITDA of RAPP is -$29.73M

What is the all-time high quarterly EBITDA for Rapport Therapeutics, Inc.?

Rapport Therapeutics, Inc. all-time high quarterly EBITDA is -$5.18M

What is Rapport Therapeutics, Inc. quarterly EBITDA year-on-year change?

Over the past year, RAPP quarterly EBITDA has changed by -$8.31M (-38.79%)

What is Rapport Therapeutics, Inc. TTM EBITDA?

The current TTM EBITDA of RAPP is -$109.10M

What is the all-time high TTM EBITDA for Rapport Therapeutics, Inc.?

Rapport Therapeutics, Inc. all-time high TTM EBITDA is -$5.18M

What is Rapport Therapeutics, Inc. TTM EBITDA year-on-year change?

Over the past year, RAPP TTM EBITDA has changed by -$50.14M (-85.05%)
On this page